RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MUSSO M
Collezione AOU Alessandria

Items : 6

A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas. in Blood cancer discovery / Blood Cancer Discov. 2024 Sep 3;5(5):318-330. doi: 10.1158/2643-3230.BCD-24-0052.

2024
AOU Alessandria
AOU Città della Salute di Torino

Massaia M; Cavallo F; Ladetto M; Olivieri J; Krampera M; Grillo G; Russo D; Musso M; Barbui AM; Botto B; Sorà F; Santoro A; Bonifazi F; Dodero A; Martino M; Carrabba MG; Cutini I; Tisi MC; Di Rocco A; Chiusolo P; Ljevar S; Bramanti S; Casadei B; Stella F; Chiappella A; Arcaini L; Pennisi M; Zinzani PL; Miceli R; et alii...

Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE study. in British journal of haematology / Br J Haematol. 2024 Oct;205(4):1356-1360. doi: 10.1111/bjh.19590. Epub 2024 Jun 15.

2024
AOU Alessandria
AOU Città della Salute di Torino

Aiello A; Corradini P; Dodero A; Olivieri J; Trotta GE; Novo M; Musso M; Di Chio MC; Brunello L; Tisi MC; Barbui AM; Farina M; Di Rocco A; Chiusolo P; Bramanti S; Ljevar S; Casadei B; Barone A; Chiappella A;

Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study. in Leukemia / Leukemia. 2024 May;38(5):1107-1114. doi: 10.1038/s41375-024-02213-x. Epub 2024 Mar 8.

2024
AOU Alessandria
AOU Città della Salute di Torino

Corradini P; Zinzani PL; Miceli R; Guidetti A; Saccardi R; Bermema A; Ferrari S; Martelli M; Ferreri AJM; Pennisi M; Galli E; Patriarca F; Zacchi G; Krampera M; Grillo G; Novo M; Martino M; Farina M; Musso M; Tisi MC; Bramanti S; Bonifazi F; Dodero A; Cutini I; Angelillo P; Barbui AM; Ljevar S; Magni M; Di Rocco A; et alii...

Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Jun;57(6):949-958. doi: 10.1038/s41409-022-01626-5. Epub 2022 Apr 12.

2022
AOU Alessandria
AOU Città della Salute di Torino

Oldani E; Vallisa D; Sacchi N; Vacca A; Tringali S; Parma M; Palazzo G; Onida F; Musso M; Grillo G; Casini M; Baronciani D; Nozzoli C; Cupri A; Luppi M; Chiusolo P; Carluccio P; Sorasio R; Santarone S; Proia A; Picardi A; Cilloni D; Carella AM; Di Grazia C; Brunello L; Patriarca F; Iori AP; Grassi A; Busca A; et alii...

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab. in Bone marrow transplantation / Bone Marrow Transplant. 2020 Aug;55(8):1580-1587. doi: 10.1038/s41409-020-0855-z. Epub 2020 Mar 13.

2020
AOU Alessandria

Bacigalupo A; Angelucci E; Raiola AM; Varaldo R; Di Grazia C; Gualandi F; Benedetti E; Risitano A; Musso M; Zallio F; Ciceri F; Chiusolo P; Sica S; Rambaldi A; Bonifazi F; Parma M; Martino M; Onida F; Iori AP; Selleri C; Borghero C; Bertaina A; Prezioso L; Algeri M; Locatelli F;

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial. in Haematologica / Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2019
AOU Alessandria
AOU San Luigi di Orbassano

Mantoan B; Gueli A; Billio A; Angrilli F; Perrone T; Lanza F; Semenzato G; Parvis G; Dondi A; Narni F; Zallio F; Zoli V; Devizzi L; Tucci A; Di Raimondo F; Stelitano C; Rota-Scalabrini D; Ciceri F; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; Pulsoni A; Barbui AM; Patti C; Boccomini C; Benedetti F; Bruna R; et alii...